KD-PÜR

Serial Number 77897081
Registration 4161617
800

Registration Progress

Application Filed
Dec 18, 2009
Under Examination
Apr 12, 2011
Approved for Publication
Feb 15, 2011
Published for Opposition
Feb 15, 2011
Registered
Jun 19, 2012

Basic Information

Serial Number
77897081
Registration Number
4161617
Filing Date
December 18, 2009
Registration Date
June 19, 2012
Published for Opposition
February 15, 2011
Renewal Date
June 19, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jan 8, 2022
Registration
Registered
Classes
040

Rights Holder

K.D. PHARMA BEXBACH GMBH

16
Address
AM KRAFTWERK 6
BEXBACH 66450
DE

Ownership History

Bioseutica plc

Original Applicant
16
British Columbia CA

Bioseutica plc

Owner at Publication
16
British Columbia CA

Bioseutica plc

Original Registrant
16
Valletta MT

K.D. PHARMA BEXBACH GMBH

New Owner After Registration #1
16
BEXBACH DE

Legal Representation

Attorney
Andrew N. Spivak

USPTO Deadlines

Next Deadline
2538 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2012-06-19)
Due Date
June 19, 2032
Grace Period Ends
December 19, 2032

Application History

50 events
Date Code Type Description
Jan 8, 2022 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 8, 2022 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 8, 2022 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 6, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 27, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED
Jun 19, 2021 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 2, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 2, 2017 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 2, 2017 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 19, 2017 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 19, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED
May 8, 2013 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 11, 2013 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 11, 2013 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 19, 2012 R.PR A REGISTERED-PRINCIPAL REGISTER
May 17, 2012 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 16, 2012 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
May 15, 2012 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 14, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 8, 2012 CNRT W SU - NON-FINAL ACTION - WRITTEN
May 8, 2012 GNRT O NON-FINAL ACTION E-MAILED
May 8, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2012 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Apr 27, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 11, 2012 EISU I TEAS STATEMENT OF USE RECEIVED
Apr 11, 2012 IUAF S USE AMENDMENT FILED
Oct 7, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 5, 2011 EXT1 S SOU EXTENSION 1 FILED
Oct 5, 2011 EX1G S SOU EXTENSION 1 GRANTED
Apr 12, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 15, 2011 PUBO A PUBLISHED FOR OPPOSITION
Feb 15, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 6, 2011 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 6, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2010 CNSI R SUSPENSION INQUIRY WRITTEN
Nov 17, 2010 GNSI S INQUIRY TO SUSPENSION E-MAILED
Nov 17, 2010 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 1, 2010 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 17, 2010 CNSL R SUSPENSION LETTER WRITTEN
May 17, 2010 GNSL S LETTER OF SUSPENSION E-MAILED
May 17, 2010 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 14, 2010 ALIE A ASSIGNED TO LIE
May 14, 2010 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2010 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED

Detailed Classifications

Class 040
Extraction of lipids and other by-products from fish oil and plants for others; manufacture of pharmaceutical and neutraceutical preparations containing Omega-3 extracts in the form of oils, powders and capsules for others
First Use Anywhere: Jan 20, 2009
First Use in Commerce: Jan 20, 2009

Classification

International Classes
040